[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AceStocks88 Tanner H. Tanner H. posts on X about $lyra, market cap, runner, upside the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1404048603706970114/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +1,236% - X Months XXXXXX +246% - X Year XXXXXX +56% ### Mentions: XX [#](/creator/twitter::1404048603706970114/posts_active)  - X Week XX +77% - X Month XX +620% - X Months XX +235% - X Year XXX +163% ### Followers: XXX [#](/creator/twitter::1404048603706970114/followers)  - X Week XXX +4.10% - X Month XXX +8% - X Months XXX +24% - X Year XXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1404048603706970114/influencer_rank)  ### Social Influence [#](/creator/twitter::1404048603706970114/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXXX% [finance](/list/finance) XXXXX% **Social topic influence** [$lyra](/topic/$lyra) #2, [market cap](/topic/market-cap) #1025, [runner](/topic/runner) #1064, [upside](/topic/upside) 3.7%, [$qnrx](/topic/$qnrx) 3.7%, [cuts](/topic/cuts) 3.7%, [$prax](/topic/$prax) 3.7%, [$mira](/topic/$mira) 3.7%, [$vivk](/topic/$vivk) 3.7%, [$sprb](/topic/$sprb) XXX% **Top accounts mentioned or mentioned by** [@stockplaymaker1](/creator/undefined) [@moonmarket](/creator/undefined) [@mmatters22596](/creator/undefined) [@hedgenomix](/creator/undefined) [@spartatrades](/creator/undefined) [@investingcom](/creator/undefined) [@richtrades100](/creator/undefined) [@cofffree](/creator/undefined) [@sarwanjohn](/creator/undefined) [@dehixtrades](/creator/undefined) [@ttstocks](/creator/undefined) [@superduperinvst](/creator/undefined) [@uavcorp](/creator/undefined) [@heartratetrader](/creator/undefined) [@mitchpicks](/creator/undefined) [@fearl3ss_qt](/creator/undefined) **Top assets mentioned** [LYRA (LYRA)](/topic/$lyra) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Chains of War (MIRA)](/topic/$mira) ### Top Social Posts [#](/creator/twitter::1404048603706970114/posts) --- Top posts by engagements in the last XX hours "@Investingcom $LYRA IMO. Market Cap of 11.3M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue" [X Link](https://x.com/AceStocks88/status/1979775722463052282) [@AceStocks88](/creator/x/AceStocks88) 2025-10-19T05:04Z XXX followers, XXX engagements "@richtrades100 Even lower now.still seems like risk is skewed to upside especially with a market cap of only 11M or so and a phase X asset" [X Link](https://x.com/AceStocks88/status/1980021214648348964) [@AceStocks88](/creator/x/AceStocks88) 2025-10-19T21:20Z XXX followers, X engagements "@stockplaymaker1 $LYRA small float bio worth watching w/ Phase X assets and sub 15M market cap. 1.64M OS; 1.12M float" [X Link](https://x.com/AceStocks88/status/1975980988477079954) [@AceStocks88](/creator/x/AceStocks88) 2025-10-08T17:45Z XXX followers, XXX engagements "@coff_free @SarwanJohn I like $LYRA as well. It has an active Phase X asset; cash runway into 2026 + just 1.6ish Million OS. Float just over 1M" [X Link](https://x.com/AceStocks88/status/1976667513481236723) [@AceStocks88](/creator/x/AceStocks88) 2025-10-10T15:13Z XXX followers, XXX engagements "@Dehix_Trades Not sure about next Friday but I like $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M" [X Link](https://x.com/AceStocks88/status/1976756536245731675) [@AceStocks88](/creator/x/AceStocks88) 2025-10-10T21:07Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M" [X Link](https://x.com/AceStocks88/status/1976868786310373850) [@AceStocks88](/creator/x/AceStocks88) 2025-10-11T04:33Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M" [X Link](https://x.com/AceStocks88/status/1977052540966756416) [@AceStocks88](/creator/x/AceStocks88) 2025-10-11T16:43Z XXX followers, XXX engagements "@MoonMarket_ $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M" [X Link](https://x.com/AceStocks88/status/1977052710819017158) [@AceStocks88](/creator/x/AceStocks88) 2025-10-11T16:44Z XXX followers, XXX engagements "@MoonMarket_ I believe $LYRA is presenting positive Ph3 data as well on Monday 10/13" [X Link](https://x.com/AceStocks88/status/1977052808563376498) [@AceStocks88](/creator/x/AceStocks88) 2025-10-11T16:44Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA and $QNRX" [X Link](https://x.com/AceStocks88/status/1977219713651352036) [@AceStocks88](/creator/x/AceStocks88) 2025-10-12T03:48Z XXX followers, XXX engagements "@MMatters22596 $LYRA" [X Link](https://x.com/AceStocks88/status/1977219964554678458) [@AceStocks88](/creator/x/AceStocks88) 2025-10-12T03:49Z XXX followers, XXX engagements "@MMatters22596 Agree this is a good time for biotech with rate cuts (hopefully) & better access to financing. More consolidation and M & A activity in space too. Like late stage + commercial in particular. One example is $LYRA w/ Ph3 asset and a successful trial already. Many though" [X Link](https://x.com/AceStocks88/status/1977509758266392783) [@AceStocks88](/creator/x/AceStocks88) 2025-10-12T23:00Z XXX followers, XXX engagements "@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS" [X Link](https://x.com/AceStocks88/status/1978553456521589155) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:07Z XXX followers, XXX engagements "@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech" [X Link](https://x.com/AceStocks88/status/1978554108127711611) [@AceStocks88](/creator/x/AceStocks88) 2025-10-15T20:10Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX" [X Link](https://x.com/AceStocks88/status/1978867561254080637) [@AceStocks88](/creator/x/AceStocks88) 2025-10-16T16:56Z XXX followers, XXX engagements "@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here" [X Link](https://x.com/AceStocks88/status/1979318043353456810) [@AceStocks88](/creator/x/AceStocks88) 2025-10-17T22:46Z XXX followers, XX engagements "@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split" [X Link](https://x.com/AceStocks88/status/1979531933911805995) [@AceStocks88](/creator/x/AceStocks88) 2025-10-18T12:56Z XXX followers, XXX engagements "@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 11.3M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Seems way undervalued to me" [X Link](https://x.com/AceStocks88/status/1979511164523434238) [@AceStocks88](/creator/x/AceStocks88) 2025-10-18T11:33Z XXX followers, XXX engagements "@stockplaymaker1 Maybe $LYRA 1.6M OS market cap only 11M" [X Link](https://x.com/AceStocks88/status/1979665176602534114) [@AceStocks88](/creator/x/AceStocks88) 2025-10-18T21:45Z XXX followers, XXX engagements "@HeartRateTrader For a longer term I really like $LYRA. Its a biotech with an 11.3M market cap but it has an asset in Phase X with one successful trial already. 1.6M OS around 1.2M float. Decent cash on hand too" [X Link](https://x.com/AceStocks88/status/1979952100629950886) [@AceStocks88](/creator/x/AceStocks88) 2025-10-19T16:45Z XXX followers, XXX engagements "@Mitch___Picks For a longer term I really like $LYRA. Its a biotech with an 11.3M market cap but it has an asset in Phase X with one successful trial already. 1.6M OS around 1.2M float. Decent cash on hand too" [X Link](https://x.com/AceStocks88/status/1980039253296857496) [@AceStocks88](/creator/x/AceStocks88) 2025-10-19T22:31Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AceStocks88 Tanner H.
Tanner H. posts on X about $lyra, market cap, runner, upside the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +1,236%
- X Months XXXXXX +246%
- X Year XXXXXX +56%
Mentions: XX #
- X Week XX +77%
- X Month XX +620%
- X Months XX +235%
- X Year XXX +163%
Followers: XXX #
- X Week XXX +4.10%
- X Month XXX +8%
- X Months XXX +24%
- X Year XXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence cryptocurrencies XXXXX% finance XXXXX%
Social topic influence $lyra #2, market cap #1025, runner #1064, upside 3.7%, $qnrx 3.7%, cuts 3.7%, $prax 3.7%, $mira 3.7%, $vivk 3.7%, $sprb XXX%
Top accounts mentioned or mentioned by @stockplaymaker1 @moonmarket @mmatters22596 @hedgenomix @spartatrades @investingcom @richtrades100 @cofffree @sarwanjohn @dehixtrades @ttstocks @superduperinvst @uavcorp @heartratetrader @mitchpicks @fearl3ss_qt
Top assets mentioned LYRA (LYRA) Praxis Precision Medicines, Inc. Common Stock (PRAX) Chains of War (MIRA)
Top Social Posts #
Top posts by engagements in the last XX hours
"@Investingcom $LYRA IMO. Market Cap of 11.3M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue"
X Link @AceStocks88 2025-10-19T05:04Z XXX followers, XXX engagements
"@richtrades100 Even lower now.still seems like risk is skewed to upside especially with a market cap of only 11M or so and a phase X asset"
X Link @AceStocks88 2025-10-19T21:20Z XXX followers, X engagements
"@stockplaymaker1 $LYRA small float bio worth watching w/ Phase X assets and sub 15M market cap. 1.64M OS; 1.12M float"
X Link @AceStocks88 2025-10-08T17:45Z XXX followers, XXX engagements
"@coff_free @SarwanJohn I like $LYRA as well. It has an active Phase X asset; cash runway into 2026 + just 1.6ish Million OS. Float just over 1M"
X Link @AceStocks88 2025-10-10T15:13Z XXX followers, XXX engagements
"@Dehix_Trades Not sure about next Friday but I like $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-10T21:07Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T04:33Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T16:43Z XXX followers, XXX engagements
"@MoonMarket_ $LYRA low float (1.12M) low OS (1.64M) biotech w/ Phase X asset for rhino sinusitis. Cash runway into 2026. Former runner to near XX. Market cap 15M"
X Link @AceStocks88 2025-10-11T16:44Z XXX followers, XXX engagements
"@MoonMarket_ I believe $LYRA is presenting positive Ph3 data as well on Monday 10/13"
X Link @AceStocks88 2025-10-11T16:44Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA and $QNRX"
X Link @AceStocks88 2025-10-12T03:48Z XXX followers, XXX engagements
"@MMatters22596 $LYRA"
X Link @AceStocks88 2025-10-12T03:49Z XXX followers, XXX engagements
"@MMatters22596 Agree this is a good time for biotech with rate cuts (hopefully) & better access to financing. More consolidation and M & A activity in space too. Like late stage + commercial in particular. One example is $LYRA w/ Ph3 asset and a successful trial already. Many though"
X Link @AceStocks88 2025-10-12T23:00Z XXX followers, XXX engagements
"@TT_stocks_ I like $LYRA for a watch anyway. Has an active Phase X asset and previously ran from X to XX. FDA wants one more trial but still relatively cheap here. 1.6M OS"
X Link @AceStocks88 2025-10-15T20:07Z XXX followers, XXX engagements
"@SuperDuperInvst If $LYRA gets partnership news for financing Ph3 trial or other big news it might. 1.6M OS Biotech"
X Link @AceStocks88 2025-10-15T20:10Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 12.4M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. $PRAX $MIRA $VIVK $SPRB $TTRX"
X Link @AceStocks88 2025-10-16T16:56Z XXX followers, XXX engagements
"@Hedgenomix @stockplaymaker1 😂. I dont think there are too many retail owners but its a sleeper IMO. With low OS I think a market cap of 11M is diabolical for a co. with an asset in Phase X for something as common as sinusitis. They have to do one more trial due to a design issue but I like $LYRA here"
X Link @AceStocks88 2025-10-17T22:46Z XXX followers, XX engagements
"@UAV_Corp Wed also like to know exactly how close we are to obtaining the 50M term sheet closure & end of dilution / debt repayment. Is the weight balance analysis a condition precedent for that I sincerely hope there will be no further AS raises and no reverse split"
X Link @AceStocks88 2025-10-18T12:56Z XXX followers, XXX engagements
"@stockplaymaker1 $LYRA under the radar biotech IMO. Market Cap of 11.3M; 1.6M OS; 1.2ishM Float. Has Active Phase X asset that ALREADY had one successful trial. Working with FDA on new trial to address design issue. Former mover from X to around XX. Seems way undervalued to me"
X Link @AceStocks88 2025-10-18T11:33Z XXX followers, XXX engagements
"@stockplaymaker1 Maybe $LYRA 1.6M OS market cap only 11M"
X Link @AceStocks88 2025-10-18T21:45Z XXX followers, XXX engagements
"@HeartRateTrader For a longer term I really like $LYRA. Its a biotech with an 11.3M market cap but it has an asset in Phase X with one successful trial already. 1.6M OS around 1.2M float. Decent cash on hand too"
X Link @AceStocks88 2025-10-19T16:45Z XXX followers, XXX engagements
"@Mitch___Picks For a longer term I really like $LYRA. Its a biotech with an 11.3M market cap but it has an asset in Phase X with one successful trial already. 1.6M OS around 1.2M float. Decent cash on hand too"
X Link @AceStocks88 2025-10-19T22:31Z XXX followers, XXX engagements